A 'missed opportunity' to tackle the next pandemic with patent rights; Pfizer's big purchase raises biotech market hopes

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by          STAT+: Why a controversial patent rights waiver could be a 'missed opportunity' to tackle the next pandemic By Ed Silverman Paul White/AP Adopting a controversial Covid-19 patent waiver would be a 'missed opportunity' to tackle the next pandemic, one expert argues. Read More STAT+: Pfizer to buy Biohaven for $11.6 billion, raising hopes for the broader biotech market By Matthew Herper Mark Lennihan/AP Investors are likely to see the deal as a sign that large pharma companies might finally start purchasing smaller biotech firms. Read More STAT+: Flagship Pioneering hires lobbyists, a first among biotech venture firms By Nicholas Florko BRENDAN SMIALOWSKI/AFP via Getty Images Flagship Pioneering, the venture capital firm behind Moderna, hired five lobbyists in Washington — a first among biotech-focused VCs. Read More Sponsor content by Biotechnology Innovation Organization (BIO) BIO International Convention 2022 Endless opportunities to share, partner, and learn. Join us in person, June 13-16 in San Diego for the BIO International Convention 2022. Biotech brought the world back from the brink. Now we can get together to celebrate, build on your accomplishments, and make the impossible possible. STAT+: It took years, but the failure of Northwest Bio's brain cancer vaccine is now in the open By Adam Feuerstein After years of delays and excuses, the company disclosed final results from a late-stage clinical trial of its personalized cancer vaccine. Read More Tuesday, May 10, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser